Krynica Vitamin S.A. (WSE:KVT)
10.35
+0.20 (1.97%)
At close: Dec 4, 2025
Krynica Vitamin Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 374.5 | 387.89 | 357.12 | 377.16 | 395.31 | 445.94 | Upgrade
|
| Other Revenue | - | - | - | - | 0 | - | Upgrade
|
| Revenue | 374.5 | 387.89 | 357.12 | 377.16 | 395.31 | 445.94 | Upgrade
|
| Revenue Growth (YoY) | -1.52% | 8.62% | -5.31% | -4.59% | -11.35% | 50.26% | Upgrade
|
| Cost of Revenue | 309.33 | 323.54 | 304.63 | 310.91 | 336.78 | 326.33 | Upgrade
|
| Gross Profit | 65.17 | 64.36 | 52.49 | 66.25 | 58.53 | 119.61 | Upgrade
|
| Selling, General & Admin | 43.3 | 48.5 | 44.66 | 44.87 | 40.28 | 36.71 | Upgrade
|
| Other Operating Expenses | 1.21 | -3.34 | -0.77 | 0.51 | -5.14 | 7.29 | Upgrade
|
| Operating Expenses | 44.51 | 45.17 | 43.88 | 45.38 | 35.15 | 44 | Upgrade
|
| Operating Income | 20.67 | 19.19 | 8.61 | 20.88 | 23.39 | 75.61 | Upgrade
|
| Interest Expense | -2.37 | -3.62 | -4.32 | -3.56 | -0.91 | -0.97 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0.08 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.09 | 0.62 | 0.62 | 1.02 | 1.3 | -1.84 | Upgrade
|
| EBT Excluding Unusual Items | 18.21 | 16.19 | 4.91 | 18.34 | 23.86 | 72.81 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | 0.04 | 0.09 | -0.05 | -0.06 | 0.04 | Upgrade
|
| Asset Writedown | -3.26 | -2.42 | 0.37 | -4.14 | -2.8 | -1.3 | Upgrade
|
| Other Unusual Items | - | - | -12.1 | - | - | - | Upgrade
|
| Pretax Income | 15.01 | 13.81 | -6.74 | 14.15 | 21 | 71.55 | Upgrade
|
| Income Tax Expense | 2.04 | 1.58 | -0.05 | 1.07 | 5.42 | 14.62 | Upgrade
|
| Net Income | 12.97 | 12.23 | -6.68 | 13.08 | 15.58 | 56.93 | Upgrade
|
| Net Income to Common | 12.97 | 12.23 | -6.68 | 13.08 | 15.58 | 56.93 | Upgrade
|
| Net Income Growth | - | - | - | -16.05% | -72.63% | 706.06% | Upgrade
|
| Shares Outstanding (Basic) | - | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | - | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| EPS (Basic) | - | 1.00 | -0.55 | 1.07 | 1.27 | 4.65 | Upgrade
|
| EPS (Diluted) | - | 1.00 | -0.55 | 1.07 | 1.27 | 4.65 | Upgrade
|
| EPS Growth | - | - | - | -16.05% | -72.63% | 706.05% | Upgrade
|
| Free Cash Flow | 6.86 | 20.19 | 13.68 | -1.75 | -7.41 | 58.06 | Upgrade
|
| Free Cash Flow Per Share | - | 1.65 | 1.12 | -0.14 | -0.60 | 4.74 | Upgrade
|
| Dividend Per Share | 0.270 | 0.270 | - | 0.200 | - | - | Upgrade
|
| Gross Margin | 17.40% | 16.59% | 14.70% | 17.57% | 14.81% | 26.82% | Upgrade
|
| Operating Margin | 5.52% | 4.95% | 2.41% | 5.54% | 5.92% | 16.96% | Upgrade
|
| Profit Margin | 3.46% | 3.15% | -1.87% | 3.47% | 3.94% | 12.77% | Upgrade
|
| Free Cash Flow Margin | 1.83% | 5.21% | 3.83% | -0.46% | -1.87% | 13.02% | Upgrade
|
| EBITDA | 34.76 | 32.81 | 22.79 | 33.53 | 35.94 | 87.37 | Upgrade
|
| EBITDA Margin | 9.28% | 8.46% | 6.38% | 8.89% | 9.09% | 19.59% | Upgrade
|
| D&A For EBITDA | 14.09 | 13.62 | 14.18 | 12.66 | 12.55 | 11.76 | Upgrade
|
| EBIT | 20.67 | 19.19 | 8.61 | 20.88 | 23.39 | 75.61 | Upgrade
|
| EBIT Margin | 5.52% | 4.95% | 2.41% | 5.54% | 5.92% | 16.96% | Upgrade
|
| Effective Tax Rate | 13.57% | 11.44% | - | 7.55% | 25.81% | 20.43% | Upgrade
|
| Revenue as Reported | 374.5 | 387.89 | 357.12 | 377.16 | 395.31 | 445.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.